Evaluating the need for cardiac MRI in patients with premature ventricular complexes
WHEN DO WE HAVE to PERFORM CARDIAC MAGNETIC RESONANCE in PATIENTS REFERRED for PREMATURE VENTRICULAR COMPLEXES by THEIR CARDIOLOGISTS
This study is trying to see if heart scans are really needed for people with premature ventricular complexes to find any hidden heart problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Salouël) |
| Trial ID | NCT06801743 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the necessity of cardiac magnetic resonance imaging (CMR) in patients referred for premature ventricular complexes (PVC) by their cardiologists. PVCs are common and can range from benign to symptomatic, but standard tests may not always detect underlying myocardial abnormalities. The study will include patients who have undergone ECG, Holter monitoring, and CMR to better understand the role of CMR in identifying potential structural heart diseases. The findings could help refine diagnostic approaches for patients experiencing PVCs.
Who should consider this trial
Good fit: Ideal candidates are patients with PVCs who have already undergone ECG, Holter ECG, and CMR.
Not a fit: Patients who oppose the use of their personal data for research or those unable to communicate in French may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the diagnostic accuracy for patients with PVCs, leading to better management of underlying heart conditions.
How similar studies have performed: While the use of CMR in assessing cardiac conditions is established, this specific approach to PVCs is less common and may provide novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with PVC who have performed ECG, Holter ECG and a CMR Exclusion Criteria: * patient showing opposition tu use his personal data for the reseach, * patient unable to express his opposition, * patient deprived of liberty, * patient with language issues (speaking or writing French)
Where this trial is running
Salouël
- Centre Hospital-Universitaire d'Amiens — Salouël, France (Recruiting)
Study contacts
- Study coordinator: Emmanuelle VERMES, MD
- Email: vermes.emmanuelle@chu-amiens.fr
- Phone: 33 + 322087302
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.